See how top analysts and institutions rate ABBV — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| Erste Group | Downgrade | Buy → Hold | 2025-10-14 | |
| HSBC Securities | Downgrade | Buy → Hold | 2025-10-01 | |
| Berenberg | Upgrade | Hold → Buy | $270 | 2025-09-17 |
| Piper Sandler | Resumed | Overweight | $231 | 2025-08-12 |
| Daiwa Securities | Upgrade | Neutral → Outperform | $214 | 2025-08-07 |
| Citigroup | Downgrade | Buy → Neutral | $205 | 2025-05-14 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 6 | 13 | 9 | 0 | 1 |
| October 2025 | 5 | 13 | 9 | 0 | 1 |
| September 2025 | 5 | 14 | 8 | 0 | 1 |
| August 2025 | 5 | 13 | 10 | 0 | 0 |
The majority of institutional investors have issued a "Buy" rating for ABBV, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
